Febuxostat
Last Updated: 02/24/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 1591 publications
Clinical Impact of Febuxostat in HFpEF Versus HFrEF: Insights from a Prospective Cohort.
Journal: Balkan medical journal
Published: January 21, 2026
A cohort study on treatment of intermission period of gout with Quzhuo Tongbi formula ()combined with febuxostat
Journal: Zhongguo gu shang = China journal of orthopaedics and traumatology
Published: January 08, 2026
Efficacy and safety of urate-lowering therapies in asymptomatic hyperuricaemia: a systematic review and network meta-analysis of key clinical outcomes.
Journal: Annals of medicine
Published: December 11, 2025
Network pharmacology combined with ultra-high-performance liquid chromatography-quadrupole time-of-flight mass spectrometry method to explore the mechanism of Shizhi Fang in treating uric acid nephropathy mice.
Journal: Journal of traditional Chinese medicine = Chung i tsa chih ying wen pan
Published: December 11, 2025
Febuxostat effectively and safely reduces serum urate in gout patients with chronic kidney disease: A prospective multicenter ULTRA registry study.
Journal: The Journal of rheumatology
Published: December 01, 2025
Cardiovascular morbidity and mortality in gout: is gout an Independent risk Factor?
Journal: Expert opinion on pharmacotherapy
Published: November 30, 2025
Novel Isoidide Subunit-Containing Xanthine Oxidase Inhibitors with Potent Hypouricemic Effects.
Journal: Journal of medicinal chemistry
Published: November 28, 2025
Tumor Lysis Syndrome Induced by Selpercatinib in Rearranged During Transfection (RET) Fusion-Positive Non-Small-Cell Lung Cancer.
Journal: Cureus
Published: November 27, 2025
Ameliorating Acute Kidney Injury Induced by Ischemia-Reperfusion by Targeting Purine Metabolism.
Journal: International journal of molecular sciences
Published: November 14, 2025
Febuxostat analogs as anti-quorum sensing and antibacterial agents.
Journal: European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences
Published: November 12, 2025
Febuxostat attenuates cyclophosphamide-induced ovarian toxicity; Role of TLR4/NFκB/NLRP3 signaling pathway in female Wistar albino rats.
Journal: Immunopharmacology and immunotoxicology
Published: November 04, 2025
Last Updated: 02/24/2026